第一三共的加入让默沙东的ADC“后宫”突然热闹起来，原本背靠默沙东“衣食无忧”的科伦博泰地位不再稳固，与其他Biotech一样需要面临ADC领域逐渐白热化的竞争，手握K药“印钞机”的默沙东随时可以选择更有竞争力的ADC取代前者产品。

Pfizer’s Mylotarg looks set for a return to the US market after FDA advisers recommended its use in acute myeloid leukaemia. The drug comes with a fascinating history, and in many ways was a ...

Pfizer will have to cut the price of its leukaemia drug Mylotarg to get regular funding from the NHS, after England’s NICE said it could only be used in about 35% of eligible patients.

Vor Biopharma Inc. (NASDAQ:VOR) announced new clinical data from its ongoing Phase 1/2 VBP101 study of patients with relapsed ...

Vor Biopharma Inc.的股价已跌至52周新低，触及0.69美元，这家生物技术公司正面临着充满挑战的市场环境。这一最新价格标志着公司股价的显著下跌，过去一年里其股价已下跌66.04%。投资者正密切关注Vor Biopharma的表现，因为该公司正在生物技术板块的波动中寻找方向，希望能出现潜在反弹或可能影响其市场地位的战略性发展。

To date, the US Food and Drug Administration has only approved four anticancer ADCs since Wyeth’s Mylotarg came to market almost 20 years ago. The travails of the ADC sector can be partly ...

Mylotarg, the first ADC approved by the FDA, is known generically as gemtuzumab ozogamicin. Early ADC linkers were very simple, such as organic chains with acid-labile hydrazone groups.

据悉，人类此前已在国际空间站使用过塑料3D打印机，但金属材料在诸多参数上具有塑料不可比拟的优势，拥有更广泛的应用范围。随着地 - 航天器距离的增加，深空任务补给问题的挑战性迅速上升。3D ...

The data demonstrated reliable engraftment, shielding from Mylotarg on-target toxicity, a broadened Mylotarg therapeutic window, and early evidence of patient benefit. The full text of the ...

Trem-cel + Mylotarg demonstrated engraftment, shielding, broadened therapeutic window, and patient benefitVCAR33ALLO demonstrates encouraging biomarker data at lowest dose New asset VADC45 with ...

Trem-cel + Mylotarg demonstrated engraftment, shielding, broadened therapeutic window, and patient benefitVCAR33ALLO demonstrates encouraging biomarker data at lowest dose New asset VADC45 with signif ...